Aldactone and Hycodan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Aldactone (spironolactone) and Hycodan (homatropine methylbromide; hydrocodone bitartrate). Common drug interactions include adrenal insufficiency among females and pulmonary embolism among males.
The phase IV clinical study analyzes what interactions people have when they take Aldactone and Hycodan. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Aldactone?
Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 46,063 Aldactone users. Check the latest studies of Aldactone.
What is Hycodan?
Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 769 Hycodan users. Check the latest studies of Hycodan.
16 people who take Aldactone and Hycodan together, and have interactions are studied.

What are the common drug interactions of Aldactone and Hycodan, by gender? *:
female:
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Ascites (accumulation of fluid in the abdominal cavity)
- Asthenia (weakness)
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dehydration (dryness resulting from the removal of water)
- Pleural effusion (water on the lungs)
- Fatigue (feeling of tiredness)
- Anaemia (lack of blood)
- Asthma
- Blood bilirubin increased
male:
- Pulmonary embolism (blockage of the main artery of the lung)
- Bacterial infection
- Febrile neutropenia (fever with reduced white blood cells)
- Generalised oedema (swelling all over the body)
- Haematoma (collection of blood outside the blood vessels)
- Oxygen saturation decreased
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pleural effusion (water on the lungs)
- Subdural haematoma (blood collects between the skull and the surface of the brain)
- Viral infection
What are the common drug interactions of Aldactone and Hycodan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Adverse event
40-49:
n/a
50-59:
- Ascites (accumulation of fluid in the abdominal cavity)
- Asthenia (weakness)
- Asthma
- Blood bilirubin increased
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dehydration (dryness resulting from the removal of water)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Malaise (a feeling of general discomfort or uneasiness)
- Disease progression
- Fatigue (feeling of tiredness)
60+:
- Pulmonary embolism (blockage of the main artery of the lung)
- Cardiac failure congestive
- Cardiomyopathy (weakening of the heart muscle)
- Disease progression
- Disease recurrence
- Dyspnoea (difficult or laboured respiration)
- Ejection fraction decreased (systolic heart failure)
What are the existing conditions these people have? *
- Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 6 people, 37.50%
- Pain: 6 people, 37.50%
- High Blood Pressure: 5 people, 31.25%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 18.75%
- Ascites (accumulation of fluid in the abdominal cavity): 3 people, 18.75%
- Pain In Extremity: 3 people, 18.75%
- Osteoporosis (bones weak and more likely to break): 3 people, 18.75%
- Nausea (feeling of having an urge to vomit): 3 people, 18.75%
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 18.75%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Aldactone and Hycodan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Aldactone and Hycodan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aldactone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Hycodan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aldactone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hycodan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on spironolactone and homatropine methylbromide; hydrocodone bitartrate (the active ingredients of Aldactone and Hycodan, respectively), and Aldactone and Hycodan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aranesp cause Biopsy Bone Abnormal? - 4 seconds ago
- Could Sandostatin Lar cause Meniere'S Disease Aggravated? - 7 seconds ago
- Could Taxol cause Fistula Discharge? - 11 seconds ago
- Could Methylprednisolone cause Post Procedural Bile Leak? - 21 seconds ago
- Could Zenpep cause Viral Infection? - 24 seconds ago
- Could Acetaminophen cause Urine Albumin/Creatinine Ratio Increased? - 35 seconds ago
- Drug interactions of Zantac and Fortaz - 40 seconds ago
- Depression and Uterine Polyp - 42 seconds ago
- Drug interactions of Prilosec and Simvastatin - 42 seconds ago
- Drug interactions of Clindamycin Hydrochloride and Solu-Medrol - 44 seconds ago